The Institute@Precision exists to accelerate the future of precision medicine by transforming biopharma expertise into accessible knowledge.
We convene the real-world voices shaping innovation – from scientists to former regulators to commercial leaders – and focus them on the most pressing challenges facing our industry. Each quarter, we take a deep dive into a single critical topic, offering not just information, but actionable insight. I@P is not a library – it's a conversation, a community, and a catalyst for progress.
Insights drawn from our deep experience
across the biopharma lifecycle
150+
25+
425+
1Q 2026 Topic: Radiopharmaceuticals
Radiopharmaceuticals Deep Dive
Radiopharmaceuticals present enormous promise for the next generation of oncology treatments. How can we address the clinical, logistical, manufacturing, and other challenges these therapies present?
1Q 2026 Topic: Asia-Pacific
Asia-Pacific Deep Dive
The Asia-Pacific pharmaceutical market, led by China, is shifting from generic manufacturing to high-value innovation, including mRNA, cell/gene therapies, and AI-led drug discovery. What happens to your development and commercialization strategy when Asia-Pacific becomes a global engine for biopharma innovation?
Precision for Medicine
Precision AQ
Precision Medicine Group was founded to transform the process of bringing new drugs to market by integrating science, technology, data, and human expertise. We work to address the fundamental changes in healthcare necessary for global health and outcomes improvement.
